201 related articles for article (PubMed ID: 35127694)
1. Systematic Elucidation of the Aneuploidy Landscape and Identification of Aneuploidy Driver Genes in Prostate Cancer.
Peng Y; Song Y; Wang H
Front Cell Dev Biol; 2021; 9():723466. PubMed ID: 35127694
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and prognosis potential of four gene promoter hypermethylation in prostate cancer.
Li Y; Meng L; Shi T; Ren J; Deng Q
Cell Biol Int; 2021 Jan; 45(1):117-126. PubMed ID: 32991011
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer DNA Methylation Analysis and Tumor Origin Identification of Carcinoma of Unknown Primary Site Based on Multi-Omics.
Liu P
Front Genet; 2021; 12():798748. PubMed ID: 35069697
[TBL] [Abstract][Full Text] [Related]
4. The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer.
Song Z; Huang Y; Zhao Y; Ruan H; Yang H; Cao Q; Liu D; Zhang X; Chen K
J Cancer; 2019; 10(6):1398-1408. PubMed ID: 31031850
[No Abstract] [Full Text] [Related]
5. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
Gu P; Yang D; Zhu J; Zhang M; He X
Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
[TBL] [Abstract][Full Text] [Related]
6. Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer.
Heidenreich B; Heidenreich A; Sesterhenn A; Srivastava S; Moul JW; Sesterhenn IA
Eur Urol; 2000 Oct; 38(4):475-82. PubMed ID: 11025389
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel key genes associated with the metastasis of prostate cancer based on bioinformatics prediction and validation.
Song F; Zhang Y; Pan Z; Hu X; Yi Y; Zheng X; Wei H; Huang P
Cancer Cell Int; 2021 Oct; 21(1):559. PubMed ID: 34696780
[TBL] [Abstract][Full Text] [Related]
8. Identification of docetaxel-related biomarkers for prostate cancer.
Peng Y; Dong S; Yang Z; Song Y; Ding J; Hou D; Wang L; Zhang Z; Li N; Wang H
Andrologia; 2021 Aug; 53(7):e14079. PubMed ID: 34021502
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer.
Wu L; Quan W; Yue G; Luo Q; Peng D; Pan Y; Zhang G
BMC Cancer; 2021 Jan; 21(1):15. PubMed ID: 33402116
[TBL] [Abstract][Full Text] [Related]
10. Aberrant
Bjerre MT; Strand SH; Nørgaard M; Kristensen H; Rasmussen AK; Mortensen MM; Fredsøe J; Mouritzen P; Ulhøi B; Ørntoft T; Borre M; Sørensen KD
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866497
[TBL] [Abstract][Full Text] [Related]
11. Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples.
Olivan M; Garcia M; Suárez L; Guiu M; Gros L; Méndez O; Rigau M; Reventós J; Segura MF; de Torres I; Planas J; de la Cruz X; Gomis RR; Morote J; Rodríguez-Barrueco R; Santamaria A
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944822
[TBL] [Abstract][Full Text] [Related]
12. TMEM45B is a novel predictive biomarker for prostate cancer progression and metastasis.
Luo F; Yang K; Wang YZ; Lin D
Neoplasma; 2018 Sep; 65(5):815-821. PubMed ID: 30249106
[TBL] [Abstract][Full Text] [Related]
13. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
14. ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
Zhang W; Shu P; Wang S; Song J; Liu K; Wang C; Ran L
Gene; 2018 Oct; 675():136-143. PubMed ID: 29966681
[TBL] [Abstract][Full Text] [Related]
15. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
[TBL] [Abstract][Full Text] [Related]
16. FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer.
Pecqueux C; Arslan A; Heller M; Falkenstein M; Kaczorowski A; Tolstov Y; Sültmann H; Grüllich C; Herpel E; Duensing A; Kristiansen G; Hohenfellner M; Navone NM; Duensing S
Urol Oncol; 2018 Aug; 36(8):365.e15-365.e26. PubMed ID: 29887238
[TBL] [Abstract][Full Text] [Related]
17. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
Liu S; Wang W; Zhao Y; Liang K; Huang Y
Front Oncol; 2020; 10():809. PubMed ID: 32547947
[No Abstract] [Full Text] [Related]
19. Comprehensive analysis of the cancer driver genes in breast cancer demonstrates their roles in cancer prognosis and tumor microenvironment.
Du XW; Li G; Liu J; Zhang CY; Liu Q; Wang H; Chen TS
World J Surg Oncol; 2021 Sep; 19(1):273. PubMed ID: 34507558
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects.
Frank S; Nelson P; Vasioukhin V
F1000Res; 2018; 7():. PubMed ID: 30135717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
